| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Aquaculture (Q1) | ||
| Dergi ISSN | 0044-8486 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 04-2020 |
| Cilt / Sayı / Sayfa | 520 / 1 / 734984–0 | DOI | 10.1016/j.aquaculture.2020.734984 |
| Makale Linki | https://linkinghub.elsevier.com/retrieve/pii/S0044848619316333 | ||
| UAK Araştırma Alanları |
Su Ürünleri
|
||
| Özet |
| The pharmacokinetics of danofloxacin was studied in rainbow trout (Oncorhynchus mykiss) after single administration by intravenous (IV), intramuscular (IM) and oral (OR) gavage at a dose of 10 mg/kg and by 10 mg/L bath for 2 h at 11.7 ± 0.8 °C. Furthermore, minimal inhibitory concentrations (MICs) of danofloxacin against a pathogenic strain of Yersinia ruckeri, Pseudomonas spp., and Aeromonas hydrophila were determined. Plasma concentrations of danofloxacin were determined using high-performance liquid chromatograph - UV and further subjected to noncompartmental analysis. Elimination half-lives for IV, IM, OR and bath administration were 25.97 h, 42.43 h, 41.04 h and 40.41 h, respectively. Peak plasma concentrations (Cmax) for IM, OR and bath administration were 3.64 ± 0.12, 2.93 ± 0.23, and 0.36 ± 0.02 μg/mL, respectively. Bioavailability was 105.87% (IM), 96.92% (OR) and 10.09% (bath). MIC … |
| Anahtar Kelimeler |
| Danofloxacin | Pharmacodynamics | Pharmacokinetics | Rainbow trout |
| Atıf Sayıları | |
| Scopus | 39 |
| Google Scholar | 48 |
| Dergi Adı | AQUACULTURE |
| Yayıncı | Elsevier B.V. |
| Açık Erişim | Hayır |
| ISSN | 0044-8486 |
| E-ISSN | 1873-5622 |
| CiteScore | 8,9 |
| SJR | 1,096 |
| SNIP | 1,302 |